Legend Biotech (LEGN) Receivables Refunds: 2020-2022
Historic Receivables Refunds for Legend Biotech (LEGN) over the last 1 years, with Dec 2022 value amounting to $3.7 million.
- Legend Biotech's Receivables Refunds rose 565.89% to $3.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $3.7 million, marking a year-over-year increase of 565.89%. This contributed to the annual value of $3.7 million for FY2022, which is 565.89% up from last year.
- According to the latest figures from Q4 2022, Legend Biotech's Receivables Refunds is $3.7 million, which was down 0.00% from $3.7 million recorded in Q3 2022.
- In the past 5 years, Legend Biotech's Receivables Refunds ranged from a high of $7.4 million in Q4 2020 and a low of $557,000 during Q4 2021.
- Its 3-year average for Receivables Refunds is $3.8 million, with a median of $3.7 million in 2022.
- In the last 5 years, Legend Biotech's Receivables Refunds plummeted by 92.46% in 2021 and then skyrocketed by 565.89% in 2022.
- Quarterly analysis of 3 years shows Legend Biotech's Receivables Refunds stood at $7.4 million in 2020, then slumped by 92.46% to $557,000 in 2021, then soared by 565.89% to $3.7 million in 2022.
- Its last three reported values are $3.7 million in Q4 2022, $3.7 million for Q3 2022, and $3.7 million during Q2 2022.